Logo image of SEV.PA

Suez. (SEV.PA) Stock Fundamental Analysis

EPA:SEV - Euronext Paris - Matif - FR0010613471

19.83  -0.05 (-0.25%)

Fundamental Rating

2

SEV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 12 industry peers in the Multi-Utilities industry. Both the profitability and financial health of SEV have multiple concerns. SEV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

SEV had positive earnings in the past year.
SEV.PA Yearly Net Income VS EBIT VS OCF VS FCFSEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 500M 1B 1.5B 2B

1.2 Ratios

Industry RankSector Rank
ROA 1.7%
ROE 10.71%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEV.PA Yearly ROA, ROE, ROICSEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 2 -2 4 -4 6

1.3 Margins

Industry RankSector Rank
OM 7.46%
PM (TTM) 3.43%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEV.PA Yearly Profit, Operating, Gross MarginsSEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 40 60 80

1

2. Health

2.1 Basic Checks

The number of shares outstanding for SEV has been increased compared to 1 year ago.
Compared to 1 year ago, SEV has a worse debt to assets ratio.
SEV.PA Yearly Shares OutstandingSEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 200M 400M 600M
SEV.PA Yearly Total Debt VS Total AssetsSEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 10B 20B 30B

2.2 Solvency

SEV has an Altman-Z score of 0.77. This is a bad value and indicates that SEV is not financially healthy and even has some risk of bankruptcy.
SEV has a Debt/Equity ratio of 2.14. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 2.14
Debt/FCF N/A
Altman-Z 0.77
ROIC/WACCN/A
WACCN/A
SEV.PA Yearly LT Debt VS Equity VS FCFSEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.09 indicates that SEV should not have too much problems paying its short term obligations.
SEV has a Quick Ratio of 1.05. This is a normal value and indicates that SEV is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.05
SEV.PA Yearly Current Assets VS Current LiabilitesSEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

SEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 252.63%, which is quite impressive.
Looking at the last year, SEV shows a small growth in Revenue. The Revenue has grown by 1.30% in the last year.
SEV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.60% yearly.
EPS 1Y (TTM)252.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%154.8%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.93%
Revenue growth 5Y2.6%
Sales Q2Q%6.67%

3.2 Future

The Earnings Per Share is expected to grow by 71.65% on average over the next years. This is a very strong growth
SEV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.04% yearly.
EPS Next Y806.26%
EPS Next 2Y220.86%
EPS Next 3Y126.33%
EPS Next 5Y71.65%
Revenue Next Year-0.63%
Revenue Next 2Y1.41%
Revenue Next 3Y1.76%
Revenue Next 5Y2.04%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SEV.PA Yearly Revenue VS EstimatesSEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
SEV.PA Yearly EPS VS EstimatesSEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.66, which indicates a rather expensive current valuation of SEV.
SEV is valuated rather cheaply when we compare the Price/Earnings ratio to 27.50, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 20.87 indicates a rather expensive valuation of SEV.
The average S&P500 Price/Forward Earnings ratio is at 36.44. SEV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.66
Fwd PE 20.87
SEV.PA Price Earnings VS Forward Price EarningsSEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.21
SEV.PA Per share dataSEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

SEV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SEV's earnings are expected to grow with 126.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y220.86%
EPS Next 3Y126.33%

3

5. Dividend

5.1 Amount

SEV has a Yearly Dividend Yield of 3.28%. Purely for dividend investing, there may be better candidates out there.
SEV's Dividend Yield is a higher than the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 3.28%

5.2 History

Dividend Growth(5Y)0%
Div Incr YearsN/A
Div Non Decr YearsN/A
SEV.PA Yearly Dividends per shareSEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 0.2 0.4 0.6 0.8 1

5.3 Sustainability

6.23% of the earnings are spent on dividend by SEV. This is a low number and sustainable payout ratio.
DP6.23%
EPS Next 2Y220.86%
EPS Next 3Y126.33%
SEV.PA Yearly Income VS Free CF VS DividendSEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 0 200M -200M 400M 600M 800M 1B
SEV.PA Dividend Payout.SEV.PA Dividend Payout, showing the Payout Ratio.SEV.PA Dividend Payout.PayoutRetained Earnings

Suez.

EPA:SEV (1/27/2022, 7:00:00 PM)

19.83

-0.05 (-0.25%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.67B
Analysts50
Price Target19.61 (-1.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.28%
Yearly Dividend0.65
Dividend Growth(5Y)0%
DP6.23%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.66
Fwd PE 20.87
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB N/A
EV/EBITDA 7.21
EPS(TTM)0.96
EY4.84%
EPS(NY)0.95
Fwd EY4.79%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.78
BVpS8.88
TBVpSN/A
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.7%
ROE 10.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 7.46%
PM (TTM) 3.43%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 2.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.05
Altman-Z 0.77
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)252.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%154.8%
EPS Next Y806.26%
EPS Next 2Y220.86%
EPS Next 3Y126.33%
EPS Next 5Y71.65%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.93%
Revenue growth 5Y2.6%
Sales Q2Q%6.67%
Revenue Next Year-0.63%
Revenue Next 2Y1.41%
Revenue Next 3Y1.76%
Revenue Next 5Y2.04%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A